Skip to content

Managing sugar Disease with homoeopathic medicine.

A study to evaluate the effectiveness of homoeopathic medicine acid phosphoricum 30 c potency versus acid phosphoricum mother tincture in management of diabetes mellitus type 2 - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081505
Enrollment
60
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Acid Phosphoricum 30C Potency / Acid Phosphoricum Mother Tincture: The study evaluates the effect of Acid Phosphoricum 30C potency and Acid Phosphoricum Mother Tincture, both homeopathi

Sponsors

Dr NiteshKumar M Babariya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Samples aged from 30 to 80 years are included. Subjects of both sexes, irrespective of socio-economic status are included. Diagnostic criteria are based mainly on clinical presentation and blood & urine investigation are included.

Exclusion criteria

Exclusion criteria: Patients Below 30 And Above 80 Years Of Age With Type 2 Diabetes Mellitus Are Excluded. Diabetes Mellitus With Complications Like Gangrene, Amputation And Retinal Damage Etc Are Excluded. Diabetes Associated With Other Systemic Diseases Which Are On Active Treatment Are Excluded. Those Not Willing To Participate In The Study. Pregnant And Lactating Mothers.

Design outcomes

Primary

MeasureTime frame
Disappearance Of The Clinical Features Of Type 2 Diabetes Mellitus, But Recurrence Of The Same With Less Intensity, With General Well-Being Of Patient,Timepoint: Baseline (Week 0): Record initial clinical features and HbA1c levels. Week 4: Assess early symptom changes and well-being. Week 8: Evaluate symptom progression and recurrence. Week 12: Review treatment response and general health. Week 24: Assess long-term improvement and relapse. Follow-up intervals may be adjusted based on patient response.

Secondary

MeasureTime frame
Glycemic Variability Monitoring fluctuations in blood glucose levels over time.Timepoint: Baseline (Week 0) Record pre-treatment fasting & postprandial glucose levels. Week 2 Assess early fluctuations & response. Week 4 Evaluate short-term variability. Week 8 Monitor trends & stabilization. Week 12 Review mid-term metabolic response. Week 24 Assess long-term effects. Additional assessments may be done as needed.

Countries

India

Contacts

Public ContactDr Nitesh Babariya

Rajkot Homoeopathic Medical College

doctorankit79@gmail.com9882244568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026